Allmed Medical Products Co.,Ltd (SHE:002950)
China
· Delayed Price · Currency is CNY 13.81
-0.35 (-2.47%)
Apr 29, 2026, 3:04 PM CST
SHE:002950 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2018 |
| Market Capitalization | 8,545 | 6,757 | 5,419 | 6,003 | 7,758 | 10,354 | Upgrade
|
| Market Cap Growth | 54.85% | 24.69% | -9.73% | -22.61% | -25.08% | -19.50% | Upgrade
|
| Enterprise Value | 8,400 | 6,402 | 5,590 | 6,190 | 8,709 | 11,541 | Upgrade
|
| Last Close Price | 13.81 | 10.92 | 8.67 | 9.38 | 12.05 | 15.81 | Upgrade
|
| PE Ratio | 34.34 | 27.15 | 14.70 | 54.38 | 19.07 | 24.01 | Upgrade
|
| Forward PE | - | 10.45 | 10.45 | 10.45 | 10.45 | 10.45 | Upgrade
|
| PS Ratio | 2.33 | 1.84 | 1.63 | 2.18 | 1.84 | 3.54 | Upgrade
|
| PB Ratio | 2.36 | 1.87 | 1.57 | 1.87 | 2.48 | 3.76 | Upgrade
|
| P/TBV Ratio | 2.61 | 2.07 | 1.72 | 2.08 | 2.78 | 4.15 | Upgrade
|
| P/FCF Ratio | 18.71 | 14.79 | 9.77 | 43.81 | 10.32 | 123.03 | Upgrade
|
| P/OCF Ratio | 11.92 | 9.42 | 7.62 | 14.18 | 6.75 | 27.62 | Upgrade
|
| EV/Sales Ratio | 2.29 | 1.74 | 1.68 | 2.25 | 2.07 | 3.95 | Upgrade
|
| EV/EBITDA Ratio | 10.04 | 7.70 | 8.45 | 15.34 | 8.64 | 21.66 | Upgrade
|
| EV/EBIT Ratio | 14.12 | 10.76 | 12.89 | 34.50 | 10.67 | 29.77 | Upgrade
|
| EV/FCF Ratio | 18.39 | 14.01 | 10.08 | 45.18 | 11.59 | 137.13 | Upgrade
|
| Debt / Equity Ratio | 0.22 | 0.22 | 0.19 | 0.30 | 0.30 | 0.47 | Upgrade
|
| Debt / EBITDA Ratio | 0.97 | 0.97 | 0.99 | 2.36 | 0.93 | 2.41 | Upgrade
|
| Debt / FCF Ratio | 1.77 | 1.77 | 1.19 | 7.01 | 1.25 | 15.32 | Upgrade
|
| Net Debt / Equity Ratio | -0.05 | -0.05 | 0.00 | 0.14 | 0.05 | 0.22 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.20 | -0.20 | -0.01 | 1.15 | 0.15 | 1.13 | Upgrade
|
| Net Debt / FCF Ratio | -0.36 | -0.36 | -0.01 | 3.39 | 0.20 | 7.16 | Upgrade
|
| Asset Turnover | 0.69 | 0.69 | 0.66 | 0.51 | 0.78 | 0.59 | Upgrade
|
| Inventory Turnover | 3.93 | 3.93 | 3.63 | 2.65 | 3.26 | 2.64 | Upgrade
|
| Quick Ratio | 1.19 | 1.19 | 1.11 | 0.72 | 0.66 | 0.78 | Upgrade
|
| Current Ratio | 1.81 | 1.81 | 1.74 | 1.34 | 1.16 | 1.37 | Upgrade
|
| Return on Equity (ROE) | 7.28% | 7.28% | 11.08% | 3.29% | 13.76% | 15.22% | Upgrade
|
| Return on Assets (ROA) | 6.97% | 6.97% | 5.34% | 2.07% | 9.49% | 4.91% | Upgrade
|
| Return on Invested Capital (ROIC) | 14.50% | 14.37% | 9.89% | 3.18% | 20.52% | 11.18% | Upgrade
|
| Return on Capital Employed (ROCE) | 13.90% | 13.90% | 11.00% | 4.80% | 22.20% | 11.50% | Upgrade
|
| Earnings Yield | 2.91% | 3.68% | 6.80% | 1.84% | 5.24% | 4.17% | Upgrade
|
| FCF Yield | 5.35% | 6.76% | 10.23% | 2.28% | 9.69% | 0.81% | Upgrade
|
| Dividend Yield | 0.42% | - | 0.69% | 0.29% | 0.50% | 1.33% | Upgrade
|
| Payout Ratio | 21.03% | 21.03% | 11.96% | 59.07% | 40.29% | 133.84% | Upgrade
|
| Buyback Yield / Dilution | 0.99% | 0.99% | 1.33% | -0.02% | -0.17% | 0.05% | Upgrade
|
| Total Shareholder Return | 1.41% | 0.99% | 2.02% | 0.26% | 0.33% | 1.38% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.